Abstract
CTLA4 blockade improved T-cell infiltration and function in glycolysis-low tumors.
©2021 American Association for Cancer Research.
2021
American Association for Cancer Research.
You do not currently have access to this content.
Skip Nav Destination
Article navigation
1 May 2021
Research Watch|
May 01 2021
Anti-CTLA4 Perturbs Treg-Based Immunosuppression in Glycolysis-Low Tumors
Cancer Discov (2021) 11 (5): 1003.
RSS Feeds